No Data
IceCure Medical's Shareholders Approve Key Agenda Items at Special Meeting
Icecure Medical Announces It Participated In the American Society Of Breast Surgeons 2025 Annual Meeting On April 30 – May 4, 2025 In Las Vegas Following Recent FDA Development On ProSense Cryoablation
IceCure Medical Announces Meeting With Leadership Of The U.S. Food And Drug Administration's Center For Devices And Radiological Health Regarding The Company's De Novo Marketing Authorization Request For Prosense In The Treatment of Early-Stage Low...
Maxim Group Maintains Icecure Medical(ICCM.US) With Buy Rating, Maintains Target Price $3
Icecure Medical's Growth Potential Highlighted by Clinical Progress and Strategic Financial Position
H.C. Wainwright Maintains Icecure Medical(ICCM.US) With Buy Rating, Maintains Target Price $2.5
SofaKing_Nuts : Thank you for the legwork.
Think $Glucotrack (GCTK.US)$ could run on news from yesterday and today as well as decent 10-Q?
Jaguar8 OP SofaKing_Nuts : Nope based on ER net loss increased YoY.
SofaKing_Nuts Jaguar8 OP : appreciate your prompt review and quick lesson
Trytosaveabit : Hey Brother! GCTK has a R/S to do soon! Last information i have is its been approved but no amount or date set! But June 2, 2025 is deadline! BTW Hehehe. Do you remember when a Professional told people that it was “going to R/S on Jan 8 to stay away” Hehehe! Well here we are 4+ months and its still not R/Sed! Hehehe.
Jaguar8 OP Trytosaveabit : HAHA because he is “professional” that is why we should listen??![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
View more comments...